Active substances
Gramicidin + Neomycin + Polymyxin b
- SFDA 1
- US FDA 7
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| POLYSPECTRAN EYE EAR DROPS | 7500,3500,0.02 IU/ml,IU/ml,mg/ml | Eye drops · Auricular use | 1 Bottle | SAR 11.20 | NCE · Prescription | DR. THILO LABORATORIES | Withdrawn by MAH · Not Marketed |
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN | 0.025MG/ML;EQ 1.75MG BASE/ML;10,000 UNITS/ML | solution/drops · ophthalmic | BAUSCH AND LOMB INC | Prescription | 31 Jan 1996 |
| NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN | 0.025MG/ML;EQ 1.75MG BASE/ML;10,000 UNITS/ML | solution/drops · ophthalmic | SCIEGEN PHARMS | Prescription | 28 Oct 2005 |
| NEOSPORIN | 0.025MG/ML;EQ 1.75MG BASE/ML;10,000 UNITS/ML | solution/drops · ophthalmic | MONARCH PHARMS | Discontinued | 3 Jul 1968 |
| NEO-POLYCIN | 0.025MG/ML;EQ 1.75MG BASE/ML;10,000 UNITS/ML | solution/drops · ophthalmic | DOW PHARM | Discontinued | |
| NEOMYCIN SULFATE AND POLYMYXIN B SULFATE GRAMICIDIN | 0.025MG/ML;EQ 1.75MG BASE/ML;10,000 UNITS/ML | solution/drops · ophthalmic | PHARMAFAIR | Discontinued | |
| NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN | 0.025MG/ML;EQ 1.75MG BASE/ML;10,000 UNITS/ML | solution/drops · ophthalmic | WATSON LABS | Discontinued | |
| NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN | 0.025MG/ML;EQ 1.75MG BASE/ML;10,000 UNITS/ML | solution/drops · ophthalmic | IPHARM | Discontinued |
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.